BCX — Bioceltix SA Cashflow Statement
0.000.00%
Last trade - 00:00- PLN450.88m
- PLN382.79m
Annual cashflow statement for Bioceltix SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | PAS | PAS | PAS | PAS | PAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.4 | -8.92 | -13.7 | -14.9 | -15.2 |
| Depreciation | |||||
| Non-Cash Items | -0.065 | -0.055 | — | -0.051 | 0.076 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.067 | 0.656 | -1.49 | -3.19 | 2.45 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.02 | -7.87 | -14.7 | -17.6 | -11.9 |
| Capital Expenditures | -0.006 | -0.352 | -0.458 | -0.243 | -1.97 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.14 | 0 | 0 | 0.159 | 0 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | 0.134 | -0.352 | -0.458 | -0.084 | -1.97 |
| Financing Cash Flow Items | -0.022 | -0.032 | -0.154 | -0.169 | -0.15 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.74 | 6.29 | 20.4 | 42 | 48.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.85 | -1.93 | 5.19 | 24.3 | 34.8 |